NCT03776032 2018-12-20
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
Amgen
Phase 3 Completed
Clinical Trials
4 trialsNCT00036023 2009-05-11
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
Amgen
Phase 2 Completed
NCT00119613 2008-08-08
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
Amgen
Phase 3 Completed
NCT00120679 2007-12-24
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
Amgen
Phase 2 Completed